Changes to Laws, Regulations, Licenses and Approvals for Pharmaceutical, Nursing Care and Childcare Businesses
First written in FY2022. 2 of 3 entries say "Restated". Latest entry: FY2026.
4 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「If amendments to laws and regulations force changes to the Group's business activities, or if institutional reforms or revisions to reimbursement rates are implemented to restrain growth in nursing care benefits, such as reductions in nursing care reimbursement rates or increases in users' out-of-pocket contributions for nursing care services, the changes could affect the Group's financial results.」
Reconfirms institutional risks relating to laws and regulations, licences and approvals, staffing standards, official prices and reimbursement revisions concerning pharmaceuticals, childcare support and nursing care. - FY2025RestatedAnnual report
「If amendments to laws and regulations force changes to the Group's business activities, or if institutional reforms or revisions to reimbursement rates are implemented to restrain growth in nursing care benefits, such as reductions in nursing care reimbursement rates or increases in users' out-of-pocket contributions for nursing care services, the changes could affect the Group's financial results.」
Reconfirms institutional risks relating to laws and regulations, licences and approvals, staffing standards, official prices and reimbursement revisions concerning pharmaceuticals, childcare support and nursing care. - FY2022First statedAnnual report
「If amendments to laws and regulations force changes to the Group's business activities, or if institutional reforms or revisions to reimbursement rates are implemented to restrain growth in nursing care benefits, such as reductions in nursing care reimbursement rates or increases in users' out-of-pocket contributions for nursing care services, the changes could affect the Group's financial results.」
Organises as business risks changes to laws and regulations, licences and approvals, staffing and operating standards, official prices and subsidy programmes relating to pharmaceuticals, long-term care insurance and child welfare.